Lanlan Shao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 4
- Extracellular vesicles in disease 2
- Advanced biosensing and bioanalysis techniques 1
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Hongyan Zhu (5 shared papers)Ye Gan (3 shared papers)Chunyan Gu (1 shared paper)Hongwei Chen (1 shared paper)Tianqing Liu (3 shared papers)Haiqin Huang (2 shared papers)Hongwei Guo (2 shared papers)Jun‐Xu Li (1 shared paper)
- Journals
- Molecular Pharmaceutics (1 paper)Pharmaceutics (1 paper)ACS Applied Materials & Interfaces (1 paper)Bioengineering & Translational Medicine (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Lanlan Shao
5 papers receiving 439 citations
Lanlan Shao's Hit Papers
Peers
Comparison fields: 5 of 56
- Cancer Research 176
- Biomaterials 78
- Molecular Biology 340
- Biomedical Engineering 134
- Immunology 43
Countries citing papers authored by Lanlan Shao
This map shows the geographic impact of Lanlan Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Shao more than expected).
Fields of papers citing papers by Lanlan Shao
This network shows the impact of papers produced by Lanlan Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Shao. The network helps show where Lanlan Shao may publish in the future.
Co-authors
The 18 scholars most cited alongside Lanlan Shao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis Hit paper breakdown → | 2019 | 355 |
| 2 | 2021 | 36 | |
| 3 | 2020 | 23 | |
| 4 | 2019 | 15 | |
| 5 | 2022 | 13 |
About Lanlan Shao
Lanlan Shao is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Immunology and Cancer Research, having authored 5 papers that have together received 442 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (2 papers), Extracellular vesicles in disease (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), MicroRNA in disease regulation (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Cancer Research (176 citations), Biomaterials (78 citations), Molecular Biology (340 citations), Biomedical Engineering (134 citations) and Immunology (43 citations). Lanlan Shao has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Hongyan Zhu, Ye Gan, Chunyan Gu, Hongwei Chen, Tianqing Liu, Haiqin Huang, Hongwei Guo, Jun‐Xu Li, Yan Chen and Lan Tang. Their work appears in journals such as Molecular Pharmaceutics, Pharmaceutics, ACS Applied Materials & Interfaces, Bioengineering & Translational Medicine and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.